Video from AACC: Beckman Coulter partners with Scopio

Leo O'Connor
Jul 31, 2022
2022 08 01 17 21 6187 Scopio And Bc 400

Danaher’s Beckman Coulter Diagnostics has announced it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood smear platforms.

Dr. Peter Soltani, senior vice president and general manager at Beckman Coulter, and Itai Hayut, cofounder and CEO of Scopio Labs, spoke to LabPulse.com and ScienceBoard.net about the partnership.

Click on the video below for the interview.

Itai Hayut of Scopio Labs and Dr. Peter Soltani of Beckman Coulter.

Latest in Agreement
Bladder Urinary 3 D Social
A. Menarini, Nucleix sign distribution agreement for bladder cancer test
September 9, 2024
Alcohol Drugs Pills Social
Carolina Liquid Chemistries, Medline sign distribution deal for POC fentanyl screening test
August 2, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Business Agreement Social
Patient Square Capital to acquire NanoString assets for $220M
March 11, 2024
Related Stories
Lab Pulse Email Header Logo Only
Companies
LabPulse.com
Dx I 9000 Analyzer Sample Rack Social
Immunoassays
Beckman Coulter analyzer developed 'from the ground up' to address IVD industry constraints
Financials Growth Revenue Business Social
Financial Results
Danaher Q3 diagnostics revenues rise 9%
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Agreement
A. Menarini, Nucleix sign distribution agreement for bladder cancer test
By LabPulse.com staff writers
A. Menarini Diagnostics and liquid biopsy firm Nucleix have signed a strategic partnership for the exclusive distribution of Nucleix's Bladder EpiCheck test.
September 9, 2024
Bladder Urinary 3 D Social
Carolina Liquid Chemistries, Medline sign distribution deal for POC fentanyl screening test
By LabPulse.com staff writers
Carolina Liquid Chemistries has forged an agreement with medical supply manufacturer and distributor Medline Industries to distribute its point-of-care fentanyl screening test kit to healthcare providers and clinical laboratories across the U.S.
August 2, 2024
Alcohol Drugs Pills Social
Siga Technologies, HHS sign $113M procurement deal for smallpox, mpox treatment
By LabPulse.com staff writers
Biotech company Siga Technologies announced that the U.S. Department of Health and Human Services (HHS) exercised a procurement option on an existing contract with Siga to deliver approximately $113 million of the firm's oral antiviral treatment TPoxx.
July 22, 2024
3 D Monkeypox Infecting Cell Social
Patient Square Capital to acquire NanoString assets for $220M
By LabPulse.com staff writers
NanoString Technologies has reached a binding agreement with Patient Square Capital in which NanoString will sell substantially all of its assets to the investment firm for $220 million.
March 11, 2024
Business Agreement Social
Flatiron Health, Guardant Health to integrate tests, EMR platform
By LabPulse.com staff writers
Flatiron Health and Guardant Health have signed an agreement to integrate Guardant’s genomic profiling test portfolio into Flatiron’s cloud-based OncoEMR electronic medical record (EMR) platform.
November 1, 2023
Business Agreement Social
Astellas snags chance to license Poseida cell therapy in $50M deal
By Nick Paul Taylor
The agreement gives Astellas first refusal for partnering on P-MUC1C-ALLO1, an allogeneic chimeric antigen receptor (CAR) T cell therapy product candidate that Poseida is developing as a treatment for solid tumors.
August 9, 2023
T Cell Social
Guardant and Illumina resolve lawsuit, reach agreement
By Nick Paul Taylor
In a statement, Guardant said the “three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies.” The request to dismiss includes “any allegations related to the subject intellectual property.”
August 7, 2023
Business Men Handshake Social
Siemens Healthineers to distribute Scopio Labs’ full-field digital cell morphology technology
By LabPulse.com staff writers
Siemens Healthineers said the Scopio X100 and Scopio X100HT imaging platforms will complement its IVD systems, including the Atellica Hema 570 and Atellica Hema 580 analyzers.
May 8, 2023
Nanoparticle Blood Social
Werfen signs distribution agreement with Thermo Fisher for hemostasis diagnostics system
By LabPulse.com staff writers
The exclusive, long-term agreement allows Barcelona-based Werfen to continue offering the HemoCell Specialized Lab Automation system.
May 4, 2023
Business Agreement Social
Agilent Technologies, Proscia ink digital pathology distribution agreement
By LabPulse.com staff writers
Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality, Agilent said.
March 8, 2023
Concentriq Dx 2 (002)
Exact Sciences executes private placement of convertible senior notes
By LabPulse.com staff writers
Under the agreement, Exact Sciences has agreed to issue to the holder $500 million aggregate principal amount of a new series of 2% convertible senior notes due in 2030.
February 23, 2023
Hands Shaking Deal Social
Quest Diagnostics, New York-Presbyterian ink laboratory services agreement
By LabPulse.com staff writers
Their strategic objective is to broaden access to laboratory services for providers in New York, Connecticut, New Jersey, and beyond.
February 14, 2023
Women Laboratory Social
Page 1 of 16
Next Page